Is Jyothy Labs Overvalued or Undervalued Right Now?
- September 1, 2026
- Posted by: Kunal Singla
- Category: Market
Jyothy Labs CMP Rs 204.61 (31 Aug 2026), up 0.56%. PE 26.32 vs industry PE 37.72. ROE 20.97%. 52W range Rs 188.10 to Rs 347.00.
Quick Answer
Jyothy Labs trades at a price to earnings ratio of 26.32, well below the industry average of 37.72, which points toward undervaluation on a simple multiple basis. The stock’s 20.97% return on equity and Rs 43.26 book value per share suggest the market may be underpricing the underlying business relative to peers. Whether Jyothy Labs is overvalued or undervalued right now depends on whether that discount reflects a genuine risk the market has priced in or simply a lack of investor attention. On valuation multiples alone, the stock currently sits below what the broader sector is priced at.
Is Jyothy Labs overvalued or undervalued right now is a question worth asking given how its price to earnings ratio compares with the rest of its sector. At the current market price of Rs 204.61, the stock trades roughly 41.0% below its 52 week high of Rs 347.00 and about 8.8% above its 52 week low of Rs 188.10.
Jyothy Labs’s share price moved up 0.56% in Monday’s session to Rs 204.61, against a market capitalisation of Rs 7,471 Cr. This article looks at the numbers, the PE ratio, price to book, return on equity, debt levels and recent earnings trends, that determine whether the current price reflects fair value or a stretched multiple, and works through the full Jyothy Labs overvalued or undervalued picture step by step.
Click Here – Get Free Investment Predictions
Jyothy Labs Overvalued or Undervalued: Valuation Metrics
| Valuation Metric | Jyothy Labs |
|---|---|
| CMP (31 Aug 2026) | Rs 204.61 |
| Market Cap | Rs 7,471 Cr |
| P/E Ratio | 26.32 |
| Industry P/E | 37.72 |
| P/B Ratio | 4.70 |
| Sector Average P/B (FMCG personal care and food) | 12.66 |
| Return on Equity (ROE) | 20.97% |
| Sector Average ROE (FMCG personal care and food) | 14.71% |
| EPS (TTM) | Rs 7.73 |
| Book Value per Share | Rs 43.26 |
| Debt to Equity | 0.03 |
| Dividend Yield | 1.72% |
| Sector Average Dividend Yield (FMCG personal care and food) | 1.85% |
| 52 Week High / Low | Rs 347.00 / Rs 188.10 |
The headline number here is the price to earnings ratio. At 26.32, the Jyothy Labs PE ratio is 0.7 times the industry average of 37.72. Measured against its FMCG personal care and food sector peers, the gap widens further on other measures too: a P/B of 4.70 against a sector average of 12.66, and an ROE of 20.97% against a sector average of 14.71%. This table alone is not enough to settle whether Jyothy Labs overvalued or undervalued is the fair read, but it is the starting point for the rest of this analysis.
Is Jyothy Labs Overvalued or Undervalued Based on Its P/E Ratio?
Based on the P/E ratio alone, Jyothy Labs looks undervalued. The stock’s PE of 26.32 sits well below the industry average of 37.72, which can reflect either a genuine bargain or a market discounting some risk in the business that is not obvious from the ratio itself. Investors relying only on the PE ratio would classify Jyothy Labs as cheaper than its peers, but the Jyothy Labs PE ratio still needs to be read alongside its return ratios and earnings quality before calling Jyothy Labs overvalued or undervalued on this measure alone.
Check Jyothy Labs’s Live Fundamentals on the Univest Screener
Jyothy Labs’s Financial Growth and Profitability
Jyothy Labs’s revenue moved from Rs 2,810.66 crore in FY2024 to Rs 2,902.56 crore in FY2025, a change of 3.3%. Net profit grew from Rs 369.30 crore to Rs 370.38 crore over the same period, a swing of roughly 0.3%.
The Jyothy Labs share price has moved alongside this earnings trend, which is part of why the stock now trades at 0.7 times the industry PE of 37.72 rather than a flat multiple.
These growth numbers feed directly into the Jyothy Labs overvalued or undervalued question, since a rich multiple is easier to justify when profit growth is accelerating than when it is flat or falling.
Download the Univest iOS App or Univest Android App to track Jyothy Labs’s live share price and valuation ratios.
Jyothy Labs Overvalued or Undervalued: The Case for Overvalued
Before getting to the bullet points, it helps to frame the Jyothy Labs overvalued or undervalued question in terms of what would make the bear case right.
- Sector-wide re-rating risk: If sentiment toward the sector turns, a PE of 26.32 still has room to compress toward the industry average of 37.72.
- Limited margin of safety: At Rs 204.61, the stock is only 41.0% below its 52 week high of Rs 347.00, leaving less room for error if earnings disappoint.
Jyothy Labs Overvalued or Undervalued: The Case Against It
The other side of the Jyothy Labs overvalued or undervalued debate rests on the quality metrics below.
- High return on equity: ROE of 20.97% against a sector average of 14.71% reflects efficient use of shareholder capital.
- Low leverage: A debt to equity ratio of 0.03 gives Jyothy Labs a comparatively strong balance sheet.
- Reasonable income: A dividend yield of 1.72% offers some cushion while the market decides on the growth story.
- 52 week range context: At Rs 204.61, the stock is 8.8% above its 52 week low of Rs 188.10, showing it has already found some support at lower levels.
Verdict: Is Jyothy Labs Overvalued or Undervalued Right Now?
On balance, Jyothy Labs looks undervalued by traditional multiples, trading at a PE of 26.32 against an industry average of 37.72. That gap can close either through the share price catching up or through the business underperforming enough to justify the discount, so the read depends on which explanation fits the company’s recent earnings trend better. A 20.97% ROE is a reasonable starting point for that judgement, but investors should weigh why the market has kept the stock at a discount before treating the gap as a straightforward opportunity. On the specific question of Jyothy Labs overvalued or undervalued, the multiples currently point one way even if the fundamentals soften that read.
What Could Change Whether Jyothy Labs Is Overvalued or Undervalued?
Two broad scenarios could shift this valuation call on Jyothy Labs in either direction. On the upside, the market recognising the gap between the PE of 26.32 and the industry average of 37.72, which would show up as the share price re-rating higher without a change in earnings. On the downside, a genuine deterioration in the business that justifies the current discount, in which case the low PE would turn out to be a fair reflection of risk rather than a bargain. Investors watching the Jyothy Labs share price over the next few quarters should track whether reported ROE holds near 20.97% and whether the PE gap versus the industry average of 37.72 widens or narrows, since both will matter more to the eventual answer on Jyothy Labs overvalued or undervalued than the current price point on its own.
Conclusion
Jyothy Labs’s numbers point to a stock that is undervalued on headline multiples, though its return ratios help explain part of the gap. Investors tracking the Jyothy Labs share price should watch whether earnings growth can keep pace with the current PE of 26.32, since that gap remains the single biggest variable in whether the stock is undervalued, fairly priced, or overvalued from here. For anyone still weighing Jyothy Labs overvalued or undervalued as a one-line takeaway, the multiples say undervalued while the return ratios offer partial support for the current price. This article is for informational purposes only and is not investment advice.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Jyothy Labs Overvalued or Undervalued: FAQs
Is Jyothy Labs overvalued or undervalued right now?
Ans. Based on a PE ratio of 26.32 against an industry average of 37.72, Jyothy Labs currently looks undervalued on relative valuation. Its 20.97% ROE is an important part of the Jyothy Labs overvalued or undervalued picture alongside the PE ratio.
What is Jyothy Labs’s current PE ratio?
Ans. Jyothy Labs’s price to earnings ratio stands at 26.32, compared with an industry average PE of 37.72. This PE gap is the main input into the Jyothy Labs overvalued or undervalued call made in this article.
What is Jyothy Labs’s return on equity?
Ans. Jyothy Labs generates a return on equity of 20.97%, against a sector average of 14.71% among FMCG personal care and food peers.
What is Jyothy Labs’s 52 week high and low?
Ans. Jyothy Labs’s 52 week high is Rs 347.00 and its 52 week low is Rs 188.10. The stock currently trades around Rs 204.61, roughly 41.0% below its high.
Does Jyothy Labs have high debt?
Ans. Jyothy Labs carries a debt to equity ratio of 0.03, which is low for its sector.
What is Jyothy Labs’s dividend yield?
Ans. Jyothy Labs offers a dividend yield of 1.72% at the current share price.
Is Jyothy Labs a good stock to buy at current levels?
Ans. Jyothy Labs’s current valuation suits investors who agree with the undervalued read on its PE ratio and are comfortable with the trade-off between its return ratios and its price. This is for informational purposes only and is not investment advice.
What is Jyothy Labs’s price to book ratio?
Ans. Jyothy Labs trades at a price to book ratio of 4.70, compared with a sector average of 12.66 among FMCG personal care and food peers.
What is the simplest way to summarise Jyothy Labs overvalued or undervalued?
Ans. On PE alone, Jyothy Labs is undervalued against its industry average of 37.72. Layer in the 20.97% ROE and the answer to Jyothy Labs overvalued or undervalued becomes more nuanced than the headline multiple suggests on its own.
